methylprednisolone hemisuccinate and Local Neoplasm Recurrence

methylprednisolone hemisuccinate has been researched along with Local Neoplasm Recurrence in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	1 (20.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	1 (20.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sun, WZ; Zhang, QY; Zhao, S	1
Dührsen, U; Dürig, J; Nückel, H	1
Aydin, S; Dührsen, U; Nückel, H	1
Cabanillas, F; Rodriguez, MA	1
Cowled, PA; Forbes, IJ; Mackenzie, L	1

Trials

1 trial(s) available for methylprednisolone hemisuccinate and Local Neoplasm Recurrence

Article	Year
Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients. Annals of hematology, 2007, Volume: 86, Issue:4 Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome	2007

Article

Year

Rituximab plus ASHAP for the treatment of patients with relapsed or refractory aggressive non-Hodgkin's lymphoma: a single-centre study of 20 patients.

Annals of hematology, 2007, Volume: 86, Issue:4

Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Resistance, Neoplasm; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Middle Aged; Nausea; Neoplasm Recurrence, Local; Neutropenia; Prognosis; Retrospective Studies; Rituximab; Salvage Therapy; Thrombocytopenia; Treatment Outcome

2007

Other Studies

4 other study(ies) available for methylprednisolone hemisuccinate and Local Neoplasm Recurrence

Article	Year
[Gemcitabine combined with cisplatin and methylprednisolone sodium succinate in chemotherapy for relapsed or refractory T cell non-Hodgkin lymphoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2010, Volume: 32, Issue:4 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Female; Gemcitabine; Humans; Lymphoma, T-Cell; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasm Recurrence, Local; Remission Induction	2010
Salvage chemotherapy according to the ASHAP protocol: a single-center study of 24 patients with relapsed or refractory aggressive non-Hodgkin's lymphomas. Annals of hematology, 2003, Volume: 82, Issue:8 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cohort Studies; Cytarabine; Doxorubicin; Female; Humans; Longitudinal Studies; Lymphoma, Non-Hodgkin; Male; Methylprednisolone Hemisuccinate; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Treatment Outcome	2003
MINE-ESHAP salvage therapy for recurrent and refractory lymphomas. Seminars in hematology, 1994, Volume: 31, Issue:2 Suppl 3 Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Mesna; Methylprednisolone Hemisuccinate; Mitoxantrone; Neoplasm Recurrence, Local; Salvage Therapy; Survival Rate	1994
Potentiation of photodynamic therapy with haematoporphyrin derivatives by glucocorticoids. Cancer letters, 1985, Volume: 29, Issue:1 Topics: Animals; Cell Line; Drug Interactions; Glucocorticoids; Hematoporphyrin Photoradiation; Hydrocortisone; Lung Neoplasms; Melanoma; Methylprednisolone; Methylprednisolone Acetate; Methylprednisolone Hemisuccinate; Mice; Mice, Inbred C57BL; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitivity Disorders; Time Factors	1985